Literature DB >> 32445005

Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function.

Sheri L Towe1, Christina S Meade1, Christine C Cloak2, Ryan P Bell1, Julian Baptiste2, Linda Chang3,4,5.   

Abstract

Globally, cannabis is the most commonly used illicit drug, with disproportionately high use among persons with HIV. Despite advances in HIV care, nearly half of persons living with HIV continue to experience neurocognitive deficits or impairments that may have negative impacts on their daily function. Chronic cannabis use may play a role in the development or exacerbation of these impairments. Here we present a review summarizing existing research detailing the effect of cannabis use associated with the neuropathogenesis of HIV. We examine evidence for possible additive or synergistic effects of HIV infection and cannabis use on neuroHIV in both the preclinical and adult human literatures, including in vitro studies, animal models, clinical neuroimaging research, and studies examining the cognitive effects of cannabis. We discuss the limitations of existing research, including methodological challenges involved with clinical research with human subjects. We identify gaps in the field and propose critical research questions to advance our understanding of how cannabis use affects neuroHIV. Graphical Abstract.

Entities:  

Keywords:  Cannabis; Endocannabinoid system; HIV; Neuropathogenesis

Year:  2020        PMID: 32445005      PMCID: PMC7680275          DOI: 10.1007/s11481-020-09921-y

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  94 in total

1.  Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.

Authors:  Changqing Xu; Douglas J Hermes; Blessing Nwanguma; Ian R Jacobs; Kenneth Mackie; Somnath Mukhopadhyay; Aron H Lichtman; Bogna Ignatowska-Jankowska; Sylvia Fitting
Journal:  Mol Cell Neurosci       Date:  2017-07-19       Impact factor: 4.314

Review 2.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

Review 3.  Synaptic functions of endocannabinoid signaling in health and disease.

Authors:  Alfonso Araque; Pablo E Castillo; Olivier J Manzoni; Raffaella Tonini
Journal:  Neuropharmacology       Date:  2017-06-15       Impact factor: 5.250

4.  Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment.

Authors:  Heidi M Crane; Mary E McCaul; Geetanjali Chander; Heidi Hutton; Robin M Nance; Joseph A C Delaney; Joseph O Merrill; Bryan Lau; Kenneth H Mayer; Michael J Mugavero; Matthew Mimiaga; James H Willig; Greer A Burkholder; Daniel R Drozd; Rob J Fredericksen; Karen Cropsey; Richard D Moore; Jane M Simoni; W Christopher Mathews; Joseph J Eron; Sonia Napravnik; Katerina Christopoulos; Elvin Geng; Michael S Saag; Mari M Kitahata
Journal:  AIDS Behav       Date:  2017-07

5.  Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation.

Authors:  L Chang; R Yakupov; C Cloak; T Ernst
Journal:  Brain       Date:  2006-04-03       Impact factor: 13.501

Review 6.  The Impact of Marijuana Use on Memory in HIV-Infected Patients: A Comprehensive Review of the HIV and Marijuana Literatures.

Authors:  Linda M Skalski; Sheri L Towe; Kathleen J Sikkema; Christina S Meade
Journal:  Curr Drug Abuse Rev       Date:  2016

7.  Marijuana as therapy for people living with HIV/AIDS: social and health aspects.

Authors:  A Fogarty; P Rawstorne; G Prestage; J Crawford; J Grierson; S Kippax
Journal:  AIDS Care       Date:  2007-02

8.  Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.

Authors:  Margaret Haney; Erik W Gunderson; Judith Rabkin; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

Review 9.  Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence.

Authors:  Marco Colizzi; Philip McGuire; Roger G Pertwee; Sagnik Bhattacharyya
Journal:  Neurosci Biobehav Rev       Date:  2016-03-14       Impact factor: 8.989

Review 10.  Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review.

Authors:  Jan Copeland; Izabella Pokorski
Journal:  Subst Abuse Rehabil       Date:  2016-05-03
View more
  6 in total

Review 1.  HIV and Substance Use in Latin America: A Scoping Review.

Authors:  Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

2.  Inhibitory Neurotransmission Is Sex-Dependently Affected by Tat Expression in Transgenic Mice and Suppressed by the Fatty Acid Amide Hydrolase Enzyme Inhibitor PF3845 via Cannabinoid Type-1 Receptor Mechanisms.

Authors:  Changqing Xu; Barkha J Yadav-Samudrala; Callie Xu; Bhupendra Nath; Twisha Mistry; Wei Jiang; Micah J Niphakis; Benjamin F Cravatt; Somnath Mukhopadhyay; Aron H Lichtman; Bogna M Ignatowska-Jankowska; Sylvia Fitting
Journal:  Cells       Date:  2022-03-02       Impact factor: 6.600

3.  HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).

Authors:  Tangui Barré; Patrick Mercié; Caroline Lions; Patrick Miailhes; David Zucman; Hugues Aumaître; Laure Esterle; Philippe Sogni; Patrizia Carrieri; Dominique Salmon-Céron; Fabienne Marcellin
Journal:  AIDS Res Ther       Date:  2022-03-15       Impact factor: 2.250

4.  HIV infection is linked with reduced error-related default mode network suppression and poorer medication management abilities.

Authors:  Jessica S Flannery; Michael C Riedel; Taylor Salo; Ranjita Poudel; Angela R Laird; Raul Gonzalez; Matthew T Sutherland
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-07-03       Impact factor: 5.067

5.  Microstructural brain abnormalities in HIV+ individuals with or without chronic marijuana use.

Authors:  Hannah A Wang; Hua-Jun Liang; Thomas M Ernst; Kenichi Oishi; Linda Chang
Journal:  J Neuroinflammation       Date:  2020-08-06       Impact factor: 8.322

Review 6.  Central Nervous System Impact of Perinatally Acquired HIV in Adolescents and Adults: an Update.

Authors:  Sharon L Nichols
Journal:  Curr HIV/AIDS Rep       Date:  2022-02-02       Impact factor: 5.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.